Our Founding Mission and Vision
Juno Biomedical, Inc originated as a UC Davis spinoff company at its founding in 2014. Juno was founded on a vision that it is possible for modern medicine to both mitigate the symptoms, and treat the root cause, of disease. At Juno Biomedical, we believe every person deserves a high quality of life.
Disease is not always avoidable, no matter how healthy of a life we live. Despite the availability of advanced technologies in our modern world, there remains a barrier in translating technology to healthcare in a safe and effective manner that can aid in healing of disease. At Juno Biomedical, Inc. we have designed a deep brain stimulation (DBS) system for potential use in returning lost motor function after subacute ischemic stroke.
The Team
Nicholas Totagrande
I am so proud of our team for the hard work that has been put into getting our flagship technology, CELLTech™, to this point in the R&D process. It takes an extraordinary amount of interdisciplinary knowledge and cross-functional teamwork to take a Class III brain implantable this far, especially alongside the teams at the FDA and the clinical staff at our selected clinical site. Our team has, and continues to, excel at reaching our combined goals.
- Nicholas Totagrande, CEO
Trisha Pfluger, M.S., PMP
Chief Scientific Officer
Allan Bernstein, M.D.
Medical Committee, Chair
Erwin Mangubat
Surgeon
Chinnu Matthew, M.Sc
Quality Engineer
Davit Mrelashvilli, M.D., MBA
Medical Committee
Jan Nolta
Advisory Board, Research
Marcia Patterson
Clinical Specialist
Carolyn Rynard, PhD
Advisory Board, Regulatory
Souvik Sen, M.D., MPH
Clinical Trial Site Investigator
Eric Severn
Webmaster
Aimee Steen
Medical Research Analyst